Clinical Trial Update: Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing sequential docetaxel followed by capecitabine to concomitant docetaxel/capecitabine in early-stage breast cancer; current status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Taxotere (docetaxel)
• Xeloda (capecitabine)

Snippet

Sponsor: Georgia Center for Oncology Research & Education | Conditions: Breast Neoplasms | Phase 2 | Status: UNKNOWN